A Data-Driven Rationale for High-Throughput SARS-CoV-2 Mass Screening Programs

被引：1
|
作者：
Pilcher, Christopher D. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, 1001 Portero Ave, San Francisco, CA 94110 USA
来源：
JAMA NETWORK OPEN | 2020年 / 3卷 / 12期
关键词：
D O I：
10.1001/jamanetworkopen.2020.31577
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] SARS-CoV-2 replicon for high-throughput antiviral screening
    Zhang, Qiu-Yan
    Deng, Cheng-Lin
    Liu, Jing
    Li, Jia-Qi
    Zhang, Hong-Qing
    Li, Na
    Zhang, Ya-Nan
    Li, Xiao-Dan
    Zhang, Bo
    Xu, Yi
    Ye, Han-Qing
    JOURNAL OF GENERAL VIROLOGY, 2021, 102 (05):
  • [2] High-throughput screening of mutations affecting SARS-CoV-2 spike functions
    Xia, Shuai
    Liu, Zezhong
    Jiang, Shibo
    TRENDS IN IMMUNOLOGY, 2023, 44 (05) : 321 - 323
  • [3] A high-throughput response to the SARS-CoV-2 pandemic
    Rasmussen, Lynn
    Sanders, Shalisa
    Sosa, Melinda
    Mckellip, Sara
    Nebane, N. Miranda
    Martinez-Gzegozewska, Yohanka
    Reece, Andrew
    Ruiz, Pedro
    Manuvakhova, Anna
    Zhai, Ling
    Warren, Brooke
    Curry, Aliyah
    Zeng, Qinghua
    Bostwick, J. Robert
    Vinson, Paige N.
    SLAS DISCOVERY, 2024, 29 (05)
  • [4] High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
    Yao Zhao
    Xiaoyu Du
    Yinkai Duan
    Xiaoyan Pan
    Yifang Sun
    Tian You
    Lin Han
    Zhenming Jin
    Weijuan Shang
    Jing Yu
    Hangtian Guo
    Qianying Liu
    Yan Wu
    Chao Peng
    Jun Wang
    Chenghao Zhu
    Xiuna Yang
    Kailin Yang
    Ying Lei
    Luke WGuddat
    Wenqing Xu
    Gengfu Xiao
    Lei Sun
    Leike Zhang
    Zihe Rao
    Haitao Yang
    Protein & Cell, 2021, 12 (11) : 877 - 888
  • [5] High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
    Zhao, Yao
    Du, Xiaoyu
    Duan, Yinkai
    Pan, Xiaoyan
    Sun, Yifang
    You, Tian
    Han, Lin
    Jin, Zhenming
    Shang, Weijuan
    Yu, Jing
    Guo, Hangtian
    Liu, Qianying
    Wu, Yan
    Peng, Chao
    Wang, Jun
    Zhu, Chenghao
    Yang, Xiuna
    Yang, Kailin
    Lei, Ying
    Guddat, Luke W.
    Xu, Wenqing
    Xiao, Gengfu
    Sun, Lei
    Zhang, Leike
    Rao, Zihe
    Yang, Haitao
    PROTEIN & CELL, 2021, 12 (11) : 877 - 888
  • [6] Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
    He, Xi
    Quan, Shuo
    Xu, Min
    Rodriguez, Silveria
    Goh, Shih Lin
    Wei, Jiajie
    Fridman, Arthur
    Koeplinger, Kenneth A.
    Carroll, Steve S.
    Grobler, Jay A.
    Espeseth, Amy S.
    Olsen, David B.
    Hazuda, Daria J.
    Wang, Dai
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (15)
  • [7] Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors
    Arya, Rimanshee
    Prashar, Vishal
    Kumar, Mukesh
    MOLECULAR BIOTECHNOLOGY, 2022, 64 (01) : 1 - 8
  • [8] Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors
    Rimanshee Arya
    Vishal Prashar
    Mukesh Kumar
    Molecular Biotechnology, 2022, 64 : 1 - 8
  • [9] Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
    Tanaka, Tomohisa
    Saito, Akatsuki
    Suzuki, Tatsuya
    Miyamoto, Yoichi
    Takayama, Kazuo
    Okamoto, Toru
    Moriishi, Kohji
    ANTIVIRAL RESEARCH, 2022, 199
  • [10] High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior
    Yang, Zhiwei
    Cai, Xinhui
    Ye, Qiushi
    Zhao, Yizhen
    Li, Xuhua
    Zhang, Shengli
    Zhang, Lei
    CURRENT DRUG TARGETS, 2023, 24 (06) : 532 - 545
12345